Efficacy

Epilepsy is a disorder that is best viewed as symptoms of disturbed electrical activity in the brain, which may be caused by a wide variety of etiologies. It is a collection of many different types of seizures that vary widely in severity appearance, cause, consequence an management. The present study was done to evaluate, which drug is more effective than the other AED, used in tertiary care hospital. We studied and analyzed the pattern usage of AED in tertiary care hospital.  And evaluated the incidence of side effects of these drugs on the subjects in the study, studied the compliance to various recommendations/protocols for usage of AED in neurology intensive care unit, and also compared the commonest and least common anti epilepsy drugs in neurology care unit. Commonest drugs use in TBI, CVA, SAH, average age of patients having seizures. The required information was collected from the case sheets of individual patients in the designed data collection form. Patient details were collected through self designed, by patient interview, by prescriptions or by medication charts. The efficacy study conducted and was evaluated according to the declaration of ”HELNSIKI” (as embedded 1996) an by the incidence of adverse event reported by the patients.

Glaucoma is an optic neuropathy associated with retinal ganglion cell death that results in visual field loss. Elevated intraocular pressure (IOP) is a primary risk factor for the disease. Glaucoma is the second leading cause of blindness worldwide. Primary open angle glaucoma alone accounts for about 75% of all primary glaucoma. Timolol maleate (non selective β adrenergic antagonist) and Latanoprost (prostaglandin analogue) are commonly used drugs. Our aim of study is to compare the ocular hypotensive effect and safety of topical Timolol maleate (0.5%) and Latanoprost (0.005%) in patients of primary open angle glaucoma. A total of 60 patients with primary open angle glaucoma were included and studied for 6 months. One group of patients were given 0.5% timolol maleate eye drops twelve hourly and other group were given 0.005% latanoprost eye drops once a day. In our study both drugs were significantly effective in lowering the intraocular pressure. The mean fall in IOP in Timolol group was 6.69mmHg (26.10%) and in Latanoprost group was 7.20mmHg (28.5%) from pretreatment values. The difference between the values of mean of reduction in IOP from baseline IOP of the two groups was 0.512 mmHg that was statistically insignificant. The systemic and ocular side effects observed in two groups were comparable and both groups were well tolerated. Timolol maleate and Latanoprost both drugs are effective significantly in lowering the IOP, well tolerated and safe with negligible systemic side effects and comparable ocular side effects.